Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 205–205 | Cite as

Osimertinib

Acquired resistance in lung adenocarcinoma: case report
Case report
  • 3 Downloads

Reference

  1. Hirakawa H, et al. A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy. Annals of Translational Medicine 6: 464, No. 23, Dec 2018. Available from: URL: http://doi.org/10.21037/atm.2018.11.25 -JapanCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations